Abacus Global Management joins Russell 2000 and 3000 indexes

Published 22/09/2025, 13:26
Abacus Global Management joins Russell 2000 and 3000 indexes

ORLANDO - Abacus Global Management, Inc. (NASDAQ:ABL), a $601 million market cap company with strong revenue growth of nearly 70% in the last twelve months, has been added to the Russell 2000® and Russell 3000® indexes, effective from the opening of U.S. equity markets on Monday, according to a company press release.

The alternative asset management firm’s inclusion comes as part of the 2025 Russell indexes reconstitution. Membership in the Russell 2000 automatically includes the company in the Russell 3000 Index and the corresponding growth and value style indexes.

"Inclusion in these Russell indices marks an important milestone in our company’s journey," said Jay Jackson, Chairman and Chief Executive Officer of Abacus. According to InvestingPro analysis, the company appears undervalued compared to its Fair Value, with analysts setting price targets between $10 and $15.

The Russell indexes serve as benchmarks for investment managers and institutional investors, with approximately $10.6 trillion in assets benchmarked against Russell’s U.S. indexes. FTSE Russell administers these widely used indexes for index funds and active investment strategies.

Abacus Global Management specializes in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services, with a focus on longevity-based assets and personalized financial planning. The company maintains a robust gross profit margin of 88%, though InvestingPro analysis reveals several key metrics and insights available to subscribers, including detailed financial health scores and comprehensive valuation metrics in the Pro Research Report.

In other recent news, Abacus Life Inc. reported a remarkable 93% increase in revenue for the second quarter of 2025, reaching $56.2 million. Alongside this, the company saw an 87% rise in adjusted net income, totaling $21.9 million. These strong financial results have led Abacus Life to revise its full-year adjusted net income guidance upwards to a range of $74 million to $80 million, suggesting a projected year-over-year growth of 59% to 72%. Despite these positive figures, the stock saw a slight decline. These developments highlight the company’s robust performance in the recent quarter. Investors may find these results noteworthy as they reflect significant growth and an optimistic outlook for the year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.